VNOV VitaNova Life Sciences Corporation

Fundamentals / CIK 0001699709 / USD

VitaNova Life Sciences Corporation reported $3.24M in revenue and a net loss of $114K for the trailing twelve months ended July 31, 2026 (up 209.5% year over year), with a 26.9% gross margin and a -2.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open VNOV in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2017 to 2026), reported in USD.

$2.99M$1.50M$0-$356KFY 2017 Revenue: $0FY 2017 Net Income: -$7.2K2017FY 2018 Revenue: $0FY 2018 Net Income: -$1.6K2018FY 2019 Revenue: $0FY 2019 Net Income: -$106K2019FY 2020 Revenue: $0FY 2020 Net Income: -$72K2020FY 2021 Revenue: $0FY 2021 Net Income: -$52K2021FY 2022 Revenue: $120KFY 2022 Net Income: $140K2022FY 2023 Revenue: $38KFY 2023 Net Income: -$24K2023FY 2024 Revenue: $571KFY 2024 Net Income: $141K2024FY 2025 Revenue: $2.66MFY 2025 Net Income: $851K2025FY 2026 Revenue: $3.03MFY 2026 Net Income: -$37K2026

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Jan 25
Revenue $3.03M $2.66M $571K $38K $120K $0 $0 $0 $0 $0
Cost of Revenue $2.11M $1.09M $193K $0 -- -- -- $0 $0 $0
Gross Profit $911K $1.58M $378K $38K -- -- -- $0 $0 $0
Selling, General & Admin $737K $166K $109K $62K -- -- -- -- -- --
Total Operating Expenses $907K $367K $172K $62K $133K $52K $72K $72K $49K -$7.2K
Operating Income $3.6K $1.21M $206K -$24K -$13K -$52K -$72K -$72K -$49K $7.2K
EBITDA -- -- -- -- -- -- -- -$72K -$49K $7.2K
Interest Expense $0 $4.5K $0 -- -- -- -- -- -- --
Income Before Tax $6.6K $1.20M $206K -$24K $140K -$52K -$72K -$72K -- --
Income Tax Expense $44K $354K $65K $0 $0 $0 $0 $0 $0 --
Net Income -$37K $851K $141K -$24K $140K -$52K -$72K -$106K -$1.6K -$7.2K
Basic EPS -$0.00 $0.10 $0.03 $0.00 $0.06 -$0.03 $0.00 $0.00 $0.00 --
Diluted EPS -- $0.09 $0.03 $0.00 $0.06 -$0.03 $0.00 $0.00 $0.00 --
Basic Shares Outstanding 8.3M 8.3M 3.5M 2.0M 2.0M 2.0M 2.0M 2.0M 1.6M --
Diluted Shares Outstanding -- 8.3M 3.5M 2.0M 2.0M 2.0M 2.0M 2.0M 1.6M 1.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Revenue $322K $1.78M $710K $427K $104K $1.95M $308K $292K
Cost of Revenue $291K $1.52M $393K $166K $35K $796K $119K $136K
Gross Profit $31K $265K $316K $261K $69K $1.16M $189K $156K
Selling, General & Admin -- $328K $220K $122K $66K $30K $31K $40K
Total Operating Expenses $153K $375K $270K $162K $101K $75K $80K $93K
Operating Income -$122K -$110K $47K $99K -$32K $1.08M $109K $63K
Interest Expense -- -- $0 $0 -- -- $813 $2.1K
Income Before Tax -- -$107K $47K $99K -$32K $1.08M $108K $61K
Income Tax Expense $939 -$125K $91K $63K $14K $280K $35K $28K
Net Income -$123K $18K -$44K $36K -$46K $800K $73K $33K
Basic EPS -$0.01 -- -$0.03 $0.00 -$0.01 -- $0.03 $0.00
Diluted EPS -- -- -$0.03 $0.00 $0.00 -- $0.03 $0.00
Basic Shares Outstanding 8.3M -- 2.8M 8.3M 8.3M -- 2.8M 8.3M
Diluted Shares Outstanding -- -- 2.8M 8.3M 8.3M -- 2.8M 8.3M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30
Cash & Cash Equivalents $1.60M $783K $593K $8.7K $23K $0 $0 $0 $4.4K $205
Cash & Short-Term Investments $1.60M $783K $593K $8.7K $23K $0 $0 $0 $4.4K $205
Accounts Receivable, Net $727K $1.27M $0 -- -- -- -- -- -- --
Inventory $106K $44K $133K $0 -- -- -- -- -- --
Other Current Assets $950 $3.4K $6.1K $0 -- -- -- -- $12K --
Total Current Assets $2.43M $2.26M $1.19M $8.7K $23K $0 $0 $0 $4.4K $5.6K
Total Non-Current Assets $16K $0 $0 $0 $0 $0 $0 $0 $31K $7.9K
Total Assets $2.45M $2.26M $1.19M $8.7K $23K $0 $0 $0 $48K $2.4K
Accounts Payable $209K $0 -- -- -- -- -- -- -- --
Deferred Revenue (Current) -- $0 -- -- -- -- -- -- -- --
Other Current Liabilities -- $820 $8.3K $0 -- -- -- -- -- --
Total Current Liabilities $396K $348K $137K $68K $58K $175K $123K $50K $0 $12K
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0 $5.6K $12K
Total Liabilities $396K $348K $137K $68K $58K $175K $123K $50K $5.6K $7.9K
Common Stock $8.3K $8.3K $25K $5.9K $5.9K $5.9K $5.9K $5.9K $5.9K $0
Retained Earnings $830K $868K $17K -$124K -$100K -$239K -$187K -$115K -$8.8K --
Total Stockholders' Equity $2.05M $1.91M $1.06M -$59K -$35K -$175K -$123K -$50K $42K -$3.7K
Total Equity $2.05M $1.91M $1.06M -$59K -$35K -$175K -$123K -$50K $42K -$3.7K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Cash & Cash Equivalents $1.60M $1.60M $1.17M $1.26M $1.05M $783K $405K $223K
Cash & Short-Term Investments $1.60M $1.60M $1.17M $1.26M $1.05M $783K $405K $223K
Accounts Receivable, Net $317K $727K $1.00M $883K $1.01M $1.27M $54K $58K
Inventory $301K $106K $130K $11K $9.1K $44K $187K $303K
Other Current Assets $950 $950 $8.0K $3.4K $3.4K $3.4K $3.4K $3.4K
Total Current Assets $2.22M $2.43M $2.31M $2.34M $2.24M $2.26M $1.32M $1.26M
Total Non-Current Assets $16K $16K $0 $0 $0 $0 $0 $0
Total Assets $2.24M $2.45M $2.31M $2.34M $2.24M $2.26M $1.32M $1.26M
Accounts Payable $123K $209K $109K $168K -- $0 -- --
Deferred Revenue (Current) -- -- -- $4.3K $11K $0 -- --
Other Current Liabilities -- -- -- $4.0K $1.2K $820 $2.8K $902
Total Current Liabilities $312K $396K $458K $438K $380K $348K $213K $224K
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $312K $396K $458K $438K $380K $348K $213K $224K
Common Stock $8.3K $8.3K $8.3K $25K $25K $8.3K $25K $25K
Retained Earnings $707K $830K $813K $857K $821K $868K $67K -$5.6K
Total Stockholders' Equity $1.93M $2.05M $1.85M $1.90M $1.86M $1.91M $1.11M $1.03M
Total Equity $1.93M $2.05M $1.85M $1.90M $1.86M $1.91M $1.11M $1.03M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Jan 25
Net Income -$37K $851K $141K -$24K $140K -$52K -$72K -$106K -$1.6K -$7.2K
Depreciation & Amortization -- -- -- -- -- -- -- $0 $0 $40
Stock-Based Compensation $179K $2.0K $1.0K $0 -- -- -- -- -- --
Change in Receivables $479K -$1.27M $0 -- -- -- -- -- -- --
Change in Inventory -$61K $89K -$133K $0 -- -- -- $0 $0 --
Change in Payables $209K -$5.2K -- -- -- -- -- -- -- --
Operating Cash Flow $814K $193K -$376K -$18K $4.1K -$42K -$54K -$49K -$9.3K -$6.5K
Investing Cash Flow -- -- -- -- -- $0 $0 $0 -$34K -$2.4K
Common Stock Issued -- -- -- -- -- -- -- $0 $47K $3.5K
Financing Cash Flow $0 -$3.0K $960K $4.0K $19K $42K $54K $45K $47K $9.1K
Net Change in Cash $814K $190K $584K -$14K $23K $0 $0 -$4.4K $4.2K --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Net Income -$123K $18K -$44K $36K -$46K $800K $73K $33K
Stock-Based Compensation -- $179K $0 $0 $0 $0 $500 $750
Change in Receivables $410K $216K -$122K $132K $253K -$1.21M $3.7K -$58K
Change in Inventory -$196K $25K -$119K -$2.1K $35K $142K $116K -$90K
Change in Payables -$86K $100K -$59K $161K $7.4K -- -- --
Operating Cash Flow $7.0K $428K -$90K $213K $264K $479K $209K $8.8K
Financing Cash Flow -- $0 $0 $0 $0 -$102K -$26K $72K
Net Change in Cash $7.0K $428K -$90K $213K $264K $378K $182K $81K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Jan 25
Gross Margin 30.1% 59.2% 66.2% 100.0% -- -- -- -- -- --
Operating Margin 0.1% 45.4% 36.0% -63.8% -11.1% -- -- -- -- --
Net Profit Margin -1.2% 32.0% 24.7% -63.8% 116.4% -- -- -- -- --
Return on Equity (ROE) -1.8% 44.6% 13.3% -- -- -- -- -- -3.8% --
Return on Assets (ROA) -1.5% 37.7% 11.8% -277.6% 604.6% -- -- -- -3.3% --
Current Ratio 6.14x 6.49x 8.71x 0.13x 0.40x 0.00x 0.00x 0.00x -- --
Quick Ratio 5.87x 6.36x 7.74x 0.13x 0.40x 0.00x 0.00x 0.00x -- --
Revenue Growth (YoY) +13.7% +366.5% +1401.8% -68.3% -- -- -- -- -- --
Gross Profit Growth (YoY) -42.2% +317.2% +894.0% -- -- -- -- -- -- --
Operating Income Growth (YoY) -99.7% +487.6% -- -- -- -- -- -- -- --
Net Income Growth (YoY) -104.4% +503.9% -- -117.3% -- -- -- -- -- --
EPS Growth (YoY) -104.0% +233.3% -- -100.0% -- -- -- -- -- --
Operating Cash Flow Growth (YoY) +322.5% -- -- -552.5% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Gross Margin 26.9% 30.1% 56.5% 60.0% 59.1% 59.2% 61.4% 62.5%
Operating Margin -2.7% 0.1% 37.4% 45.0% 46.0% 45.4% 28.6% 26.3%
Net Profit Margin -3.5% -1.2% 23.3% 30.9% 32.3% 32.0% 17.4% 15.6%
Return on Equity (ROE) -5.9% -1.8% 40.2% 45.5% 46.2% 44.6% 19.7% 14.6%
Return on Assets (ROA) -5.1% -1.5% 32.2% 36.9% 38.3% 37.7% 16.5% 12.0%
Current Ratio 7.13x 6.14x 5.05x 5.33x 5.90x 6.49x 6.21x 5.62x
Quick Ratio 6.17x 5.87x 4.76x 5.31x 5.88x 6.36x 5.33x 4.27x
Revenue Growth (YoY) +209.5% -8.6% +130.2% +46.2% -4.2% +258.7% +1081.3% --
Gross Profit Growth (YoY) -55.6% -77.1% +67.1% +67.4% -6.0% +229.2% +625.3% --
Operating Income Growth (YoY) -- -110.2% -57.1% +58.4% -- +365.1% +1730.4% --
Net Income Growth (YoY) -- -97.8% -160.8% +9.7% -- +376.6% +1126.9% --
EPS Growth (YoY) -- -- -200.0% -- -- -- -- --
Operating Cash Flow Growth (YoY) -97.4% -10.6% -143.3% +2327.6% -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001699709) · from January 25, 2017 Data through July 31, 2026 · synced Nov 21, 2026, 05:04 UTC · Open in terminal